4556 KAINOS Laboratories,Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4556

TSE Standard

KAINOS Laboratories,Inc.

1,239

JPY

-3

(-0.24%)

Dec 23, 3:10 pm JST

7.91

USD

Dec 23, 1:10 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	4,257	632	653	417	100.6	15	May 7, 2021	J-GAAP
Mar, 2022	4,614	747	777	512	126.4	25	May 9, 2022	J-GAAP
Mar, 2023	4,923	821	853	568	136.1	25	May 10, 2023	J-GAAP
Mar, 2024	5,056	865	928	637	152.3	32	May 9, 2024	J-GAAP
Mar, 2025 Guidance	5,400	800	800	550	130.5	32	May 9, 2024	J-GAAP
YoY	+6.8%	-7.5%	-13.8%	-13.7%	-14.3%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 8, 2019	5,000	550	550	380	15	J-GAAP
	Jan 24, 2020	5,000	650	650	450	15	J-GAAP
Results	May 8, 2020	4,609	608	616	398	15	J-GAAP
Mar, 2021	May 8, 2020	Available in future release
	Oct 26, 2020
Results	May 7, 2021
Mar, 2022	May 7, 2021
	Sep 27, 2021
	Mar 24, 2022
Results	May 9, 2022
Mar, 2023	May 9, 2022
	Oct 13, 2022
Results	May 10, 2023
Mar, 2024	May 10, 2023
	Mar 25, 2024
Results	May 9, 2024
Mar, 2025	May 9, 2024	5,400	800	800	550	32	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2000	5,466	-3.7	Available in future release
Mar, 2001	4,712	-13.8
Mar, 2002	4,520	-4.1
Mar, 2003	4,297	-4.9
Mar, 2004	4,121	-4.1
Mar, 2005	4,328	+5.0
Mar, 2006	4,589	+6.0
Mar, 2007	4,099	-10.7
Mar, 2008	3,959	-3.4
Mar, 2009	3,594	-9.2
Mar, 2010	4,215	+17.3
Mar, 2011	4,642	+10.1
Mar, 2012	4,864	+4.8
Mar, 2013	5,471	+12.5
Mar, 2014	5,803	+6.1
Mar, 2015	5,476	-5.6
Mar, 2016	5,345	-2.4
Mar, 2017	4,703	-12.0
Mar, 2018	4,386	-6.7
Mar, 2019	4,670	+6.5
Mar, 2020	4,609	-1.3
Mar, 2021	4,257	-7.6
Mar, 2022	4,614	+8.4
Mar, 2023	4,923	+6.7
Mar, 2024	5,056	+2.7
Mar, 2025 Guidance	5,400	+6.8	800	-7.5	800	-13.8	130.5	-14.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	4,923	821	16.7	10.45	7.24	0.63	136.1
Mar, 2024	5,056	865	17.1	10.67	7.63	0.61	152.3
Mar, 2025 Guidance	5,400	800	14.8	8.51	6.52	0.64	130.5

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	7,348	865	928	637	425.0
Fiscal Year	Mar, 1996	Mar, 2024	Mar, 2024	Mar, 2024	Mar, 1995

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	2,284	305	333	211	52.1	25	May 9, 2022	J-GAAP
Oct - Mar, 2022	2,411	310	326	210	50.3	25	May 10, 2023	J-GAAP
Oct - Mar, 2023	2,569	348	403	267	63.8	32	May 9, 2024	J-GAAP
Oct - Mar, 2024 Guidance	2,730	329	327	203	48.2	32	Oct 25, 2024	J-GAAP
YoY	+6.3%	-5.5%	-18.9%	-24.0%	-24.5%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	747	463	604	-141	-31	2,336	30.85	J-GAAP
Mar, 2023	821	534	544	-10	-191	2,679	33.01	J-GAAP
Mar, 2024	865	358	430	-72	-203	2,833	32.98	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	2,512	511	527	358	86.0	61.8	Oct 25, 2022	J-GAAP
Apr - Sep, 2023	2,487	517	525	370	88.7	56.6	Oct 25, 2023	J-GAAP
Apr - Sep, 2024	2,670	471	473	347	82.5	59.1	Oct 25, 2024	J-GAAP
YoY	+7.4%	-8.9%	-9.9%	-6.2%	-6.9%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	1,216	188	195	139	33.4	15.5	Jan 25, 2023	J-GAAP
Jan - Mar, 2023	1,195	122	131	71	17.0	10.2	May 10, 2023	J-GAAP
Apr - Jun, 2023	1,190	209	210	143	34.5	17.6	Jul 25, 2023	J-GAAP
Jul - Sep, 2023	1,297	308	315	227	54.4	23.7	Oct 25, 2023	J-GAAP
Oct - Dec, 2023	1,303	277	286	207	49.5	21.3	Jan 25, 2024	J-GAAP
Jan - Mar, 2024	1,266	71	117	60	14.3	5.6	May 9, 2024	J-GAAP
Apr - Jun, 2024	1,296	266	266	187	44.5	20.5	Jul 25, 2024	J-GAAP
Jul - Sep, 2024	1,374	205	207	160	38.1	14.9	Oct 25, 2024	J-GAAP
YoY	+5.9%	-33.4%	-34.3%	-29.5%	-30.0%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	1,235	-10.6	Available in future release
Jan - Mar, 2020	1,097	+6.0
Apr - Jun, 2020	989	-9.3
Jul - Sep, 2020	1,097	-7.5
Oct - Dec, 2020	1,088	-11.9
Jan - Mar, 2021	1,083	-1.3
Apr - Jun, 2021	1,170	+18.3
Jul - Sep, 2021	1,160	+5.7
Oct - Dec, 2021	1,138	+4.6
Jan - Mar, 2022	1,146	+5.8
Apr - Jun, 2022	1,242	+6.2
Jul - Sep, 2022	1,270	+9.5
Oct - Dec, 2022	1,216	+6.9
Jan - Mar, 2023	1,195	+4.3
Apr - Jun, 2023	1,190	-4.2
Jul - Sep, 2023	1,297	+2.1
Oct - Dec, 2023	1,303	+7.2
Jan - Mar, 2024	1,266	+5.9
Apr - Jun, 2024	1,296	+8.9
Jul - Sep, 2024	1,374	+5.9	205	-33.4	207	-34.3	38.1	-30.0

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,517	308	315	231	54.4
Fiscal Year	Dec, 2013	Sep, 2023	Sep, 2023	Sep, 2005	Sep, 2023

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	1,245.93	68.7	7,571	5,200	3,665	0.18	May 9, 2022	J-GAAP
Mar, 2023	1,358.35	69.9	8,115	5,669	4,122	0.17	May 10, 2023	J-GAAP
Mar, 2024	1,486.43	72.9	8,590	6,266	4,649	0.13	May 9, 2024	J-GAAP
Apr - Sep, 2024	ー	76.6	8,440	6,465	4,855	0.09	Oct 25, 2024	J-GAAP

KAINOS Laboratories,Inc.(4556) Financial Results